Inventor
Kevin Ronald Condroski
Inventor
Boulder, CO, US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes17%
Y02ATechnologies for adaptation to climate change15%
C07CAcyclic or carbocyclic compounds1%
C07KPeptides1%
PatentTitleYear
10,758,542Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors202010,647,730Macrocyclic compounds as TRK kinase inhibitors202010,323,022Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors201910,251,889Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors20199,902,741'Macrocyclic compounds as TRK kinase inhibitors'20189,878,997'Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors'20189,840,519'Macrocyclic compounds as TRK kinase inhibitors'20179,828,360Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors20179,822,118'Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors'20179,796,724'Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors'20179,782,415'Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors'20179,750,744'Macrocyclic compounds as Trk kinase inhibitors'20179,718,822'Macrocyclic compounds as Trk kinase inhibitors'20179,682,979'Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors'20179,562,055'Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors'20179,493,476'Macrocyclic compounds as trk kinase inhibitors'20169,079,890'Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives'20158,933,077'Glucokinase activators'20158,933,084'Macrocyclic compounds as Trk kinase inhibitors'20158,883,828'2-aminopyridine analogs as glucokinase activators'20148,865,726'Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors'20148,853,409'Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus'20148,791,123'Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors'20148,754,226'Piperidinyl-substituted lactams as GPR119 modulators'20148,431,713'2-aminopyridine derivatives as glucokinase activators'20138,362,037'2-aminopyridine analogs as glucokinase activators'20138,354,540'2-aminopyridine analogs as glucokinase activators'20138,212,045'Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus'20128,022,223'2-aminopyridine analogs as glucokinase activators'20118,022,222'Glucokinase activators'20117,932,277'Peptide inhibitors of hepatitis C virus replication'20117,897,607'Cyclic compounds'20117,879,885'Thioalkeneamides as transketolase inhibitors'20117,491,794'Macrocyclic compounds as inhibitors of viral replication'20096,579,882'Cell adhesion-inhibiting antiinflammatory compounds'20036,232,320'Cell adhesion-inhibiting antiinflammatory compounds'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2015Based in Broomfield, CO, US· patent location history
2011–2020Patents assigned to ARRAY BIOPHARMA INC (32)· patent assignee history
2011–2020Based in Boulder, CO, US· patent location history
2011–2014Based in Lafayette, CO, US· patent location history
2012–2015Patents assigned to CONDROSKI KEVIN RONALD (10)· patent assignee history
2012–2015Patents assigned to BOYD STEVEN ARMEN (7)· patent assignee history
2012–2015Patents assigned to HINKLIN RONALD JAY (7)· patent assignee history
2012–2014Patents assigned to AICHER THOMAS DANIEL (6)· patent assignee history
2014–2019Based in San Diego, CA, US· patent location history
2014–2017Based in Wallingford, CT, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 32 | 2011–2020 |
| CONDROSKI KEVIN RONALDself | 10 | 2012–2015 |
| BOYD STEVEN ARMEN | 7 | 2012–2015 |
| HINKLIN RONALD JAY | 7 | 2012–2015 |
| AICHER THOMAS DANIEL | 6 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boulder, CO, US | 9 | 2011–2020 |
| San Diego, California, US | 7 | 2014–2019 |
| Broomfield, CO, US | 7 | 2009–2015 |
| Wallingford, CT, US | 6 | 2014–2017 |
| Lafayette, CO, US | 5 | 2011–2014 |